In glioblastoma, Huang and colleagues showed that the phosphatase and tensin homolog (PTEN) exerts oncogenic activity by increasing expression of MYC and Bcl-xL, which is mediated by the gain-of-function mutant p53. Here, TP53 is linked to glioblastoma.